Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Care Bare Rx vs Lttl
Care Bare Rx and Lttl both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Care Bare Rx
Ranked #28 for women · Grade B−
Luna Fit
Best for: Women who want a needle-free route or a brand-name option on the same account, and who care more about knowing who is prescribing than about seeing the exact dose price before they start the intake.
Visit Care Bare RxLttl
Higher scoreRanked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlThe verdict for women
Lttl edges out Care Bare Rx on the Luna Fit Score, 81 to 80 (B− vs B−). Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not. The reasoning behind that number is in our Lttl write-up for women.
Care Bare Rx is still a genuine option — one of the few programs here that puts both molecules in an oral form as well as an injection, alongside a real brand-name Ozempic lane — and it names the physicians behind the prescription, which few rows here do. Weigh the six women's-health factors below against your own priorities; our full Care Bare Rx review goes through each of them, and if neither of these two is the one, the full field we rank against Care Bare Rx widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Care Bare Rx | Lttl |
|---|---|---|
| Luna Fit Score | 80/100 · B− | 81/100 · B− |
| Overall rank | #28 | #21 |
| Semaglutide | From $199/mo (per-dose price quiz-gated) | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung |
| Tirzepatide | From $199/mo (per-dose price quiz-gated) | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs |
| Coverage | All 50 states and Puerto Rico | All 50 states plus Washington D.C., with a stated caveat that some services may not be |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
Care Bare Rx
Ranked #28 · Grade B−
What we like
- Both molecules in two routes — compounded injectable semaglutide and tirzepatide, plus oral semaglutide (Rybelsus®) and an oral tirzepatide formulation
- A genuine brand-name lane with its price on the page: Ozempic® injection from $705/mo, published rather than quoted on request
- Names its prescribers with NPI numbers — Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD — which is rarer in this ranking than it should be
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- Publishes one "From $199/mo" weight-loss figure that names no molecule; the per-dose price is quiz-gated inside the intake app, and the FAQ only says "price varies by dose and medication prescribed"
- No published lab or monitoring program, which matters more if hormones are part of your picture
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Care Bare Rx nor Lttl is only worth comparing with the other. Care Bare Rx is also written up against CoreAge Rx, 13 points apart on the Luna Fit Score — see Care Bare Rx vs CoreAge Rx for women. Lttl is also written up against CoreAge Rx, 12 points apart — see Lttl against CoreAge Rx, factor by factor.
- Care Bare Rx vs CoreAge Rx
- Care Bare Rx vs Enhance MD
- Care Bare Rx vs Eden
- Lttl vs yourEra
- Lttl vs Sesame Care
- Lttl vs HealthRX
Or browse the full comparison hub.